(PharmaNewsWire.Com, July 06, 2017 ) While the preventive vaccine accounts for only 5 % of the global pharmaceuticals market, there has been a substantial growth in the recent years as a result of rising incidences of HIV cases and cancer. World Health Organization growth estimations indicate the market may increase at a tremendous rate with the introduction of new therapeutic preventive, and adult vaccines.
Vaccination is a process in which the immune system of individual is stimulated by injecting the vaccine. The vaccine Market is relatively small market compared to the pharmaceutical market and is growing at a fast rate. Many multinational companies are investing heavily in vaccine market and there are currently close to 120 new vaccines in the pipeline set to hit the market across the globe in the next few years. The vaccine market is a highly regulated market and is mostly dependent on the public purchasers and donor policies.
Increased funding for the vaccine development from the government, huge investments in the R&D department of the preventive vaccines by the major firms in the vaccine industry, technological advancements making it easier for new innovations, initiatives by NGO’s. However, there are few restrains that the market has to overcome like high capital expenditures, stringent policies by the government, high cost of treatment.
The Latin America Preventive Vaccines Market is segmented by type of vaccine as Live, attenuated vaccines, inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines. In addition, based on age groups the market is segmented as Paediatric Vaccine (Pneumococcal, MMR, Varicella, Hepatitis, Poliovirus, HIB and others) and Adult vaccines (Influenza, Cervical Cancer, Hepatitis, Zoster and others). And also, based on geography, Latin America Market is analyzed under various regions namely, Argentina, Brazil and Mexico.
Many of the major vaccine companies have been investing heavily in research and developments resulting in new innovations in the markets. The major firms in the preventive vaccine market are Johnson and Johnson, GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, Novartis AG, MedImmune, CSL Limited, Emergent BioSolutions Inc., LLC, Pfizer, Inc., and Sanofi Pasteur.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
